Ambu A/S operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ambu A/S with three other
medical equipment manufacturers in Europe:
Orthofix International NV
of the Netherlands
(2017
sales of 380.84 million Euro [US$471.33 million]
of which 43%
was BioStim),
Ypsomed Holding AG
of Switzerland
(389.56 million Swiss Francs [US$405.79 million]
of which 63%
was Delivery Devices), and
Consort Medical Plc
which is
based in the United Kingdom
(£294.00 million [US$421.81 million]
of which 59%
was Aesica).
Sales Analysis.
During the year ended September of 2017, sales at
Ambu A/S were 2.36 billion Danish Kroner (US$391.45 million).
This
is
an
increase of 13.0%
versus 2016, when the company's sales were 2.08 billion Danish Kroner.
This was the fifth consecutive year of sales increases at Ambu A/S
(and since 2012, sales have increased a total of 125%).
Sales of Pmd saw an increase
of
1.7% in 2017, from
821.00 million Danish Kroner to 835.00 million Danish Kroner.
Not all segments of Ambu A/S experienced an increase in sales in 2017:
sales of Anaesthesia fell 26.9% to 923.00 million Danish Kroner.